Novo Nordisk's European shares fell 7% as the Trump administration abandoned its proposal to cover weight loss drugs with Medicare
2025-04-07 15:04:52
Email Subscription
Newsletters and emails are now available! Delivered on time, every weekday, to keep you up
to date with North American business news.